27 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
8-K
EX-1.1
s98c2zqzh27zn
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
8-K
EX-1.1
bczz 6qalv
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
8-K
EX-10.1
0wh8kd9yiur jz
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
10-KT
cpf785sony7l0ypba
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
sy410qoe9daj923dch3
7 Oct 15
Prospectus supplement for primary offering
12:00am